Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001781002-24-000048
Filing Date
2024-10-03
Accepted
2024-10-03 16:22:42
Documents
2

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G/A  
1 primary_doc.xml SCHEDULE 13G/A 7916
2 SUBSIDIARY INFORMATION (320) ex99-1.htm EX-99 463
  Complete submission text file 0001781002-24-000048.txt   10195
Mailing Address 1345 AVENUE OF THE AMERICAS 47TH FLOOR NEW YORK NY 10105
Business Address 1345 AVENUE OF THE AMERICAS 47TH FLOOR NEW YORK NY 10105 917-769-2999
Bleichroeder LP (Filed by) CIK: 0001781002 (see all company filings)

EIN.: 842006600 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G/A

Mailing Address CAP BUSINESS CENTER RUE D'ABHOOZ, 31, B-4040 HERSTAL C9 00000
Business Address CAP BUSINESS CENTER RUE D'ABHOOZ, 31, B-4040 HERSTAL C9 00000 949-271-9221
MDxHealth SA (Subject) CIK: 0001872529 (see all company filings)

EIN.: 000000000 | State of Incorp.: C9
Type: SCHEDULE 13G/A | Act: 34 | File No.: 005-93034 | Film No.: 241351813
SIC: 8071 Services-Medical Laboratories
(CF Office: 08 Industrial Applications and Services)